Archives for Marijuana
Results Support Designof Ongoing Phase III MS Spasticity Study
Porton Down, UK, 8 September 2008: GW Pharmaceuticals plc announces positive results from a placebo-controlled “randomized withdrawal” study of Sativex® in patients with neuropathic pain due to Multiple Sclerosis (MS). This study design is described by regulators as being sufficient to satisfy the need for long-term efficacy data.
This randomized withdrawal study evaluated ...more»
Researchers find CB1 suppresses tumors, a new potential path for treatment, prevention
New preclinical research shows that cannabinoid cell surface receptor CB1 plays a tumor-suppressing role in human colorectal cancer, scientists report in the Aug. 1 edition of the journal Cancer Research.
CB1 is well-established for relieving pain and nausea, elevating mood and stimulating appetite by serving as a docking station for ...more»
There is an initiative in the works that could end up on the November ballot that allows for marijuana to be sold to anyone, and anywhere that already sells alcohol. Its being called The Inalienable Rights Enforcement Initiative. From the full text of the measure:
This initiative will amend the Constitution of California to defend and safeguard the inalienable rights of ...more»
More than nine months after it began, the only ongoing clinical study of medical marijuana on patients still needs participants. Please review the below criteria to see if you or someone you know might qualify. The study takes place in San Francisco, but the Multidisciplinary Association for Psychedelic Studies (MAPS) has generously offered to cover transportation and lodging costs so ...more»






